Fagron N.V. — Board/Management Information 2020

Apr 10, 2020

FAGRON

Company limited by shares, having made a public appeal on savings Venecoweg 20a, 9810 Nazareth, Belgium VAT BE 0890.535.026 RLE Ghent (division Ghent)

DIRECTOR'S PROFILES

Robert (Rob) ten Hoedt: independent non-executive director (proposal for resolution)

Rob Ten Hoedt, who has Dutch nationality, obtained a bachelor's degree in commercial economics at the HEAO school for higher education and a master's degree in marketing from the Netherlands Institute of Marketing (NIMA). Rob ten Hoedt is President for Europe, the Middle East and Africa (EMEA) and member of the Executive Committee of Medtronic. Mr. Ten Hoedt has held numerous international sales, marketing and general management positions in the medical technology industry and has been with Medtronic since 1991. He is also chairman of the board of Medtech Europe, the European trade association for the medical technology industry.

Alychlo NV, permanently represented by Marc Coucke: non-executive director (proposal for resolution)

Marc Coucke graduated in pharmacy from the state university of Ghent and obtained an MBA from the Vlerick Management School in Ghent, Belgium. Marc Coucke is the founder of Omega Pharma. Following the sale thereof, he invests via NV Alychlo, in which he serves as chairman, in several listed and non-listed companies.

Michael Schenck BV, permanently represented by Michael Schenck: non-executive director (proposal for resolution)

Michael Schenck holds Master's Degrees in business and management from Erasmus University Rotterdam and HEC Paris. Michael Schenck (Belgian nationality) is Investment Manager at Alychlo, the investment firm of Belgian entrepreneur Marc Coucke. Previously, Michael was Investment Manager at Waterland Private Equity. He started his career in corporate finance in France and has worked both as a volunteer and entrepreneur in Africa.